K-beauty's new frontier: Can 'cosmedical' become a category of its own?

A new category called "cosmedical" may be taking shape within the K-beauty industry.

The term refers to high-performance cosmetics with skin-regeneration properties designed for use in clinical settings to support patient treatment. Because such products must be developed on the basis of clinical evidence, they require an interdisciplinary command of cosmetic science, medicine and biotechnology. Therapeutic efficacy must also be verified through effective concentration data and clinical trials.

Cosmax, a cosmetics ODM (research, development and production) company, and Catholic University of Korea recently signed what is believed to be the first industry-academia partnership of its kind in this field. Catholic University brings together a faculty of medicine and life sciences alongside a nationwide hospital network, giving it broad educational and clinical infrastructure. Demand for cosmetics tailored to patients recovering from wounds is reported to be substantial in medical settings.

Under the agreement, Cosmax and Catholic University will jointly develop medical-grade cosmetics, with plans to carry out dermatology-based product design, development and clinical trials. Cosmax intends to combine the university's research capabilities and medical expertise with its own technology to generate synergies. The collaboration is expected to produce a new business model in the cosmedical space while advancing the sophistication of K-beauty overall.

Beyond cosmedical products, the two institutions will also pursue the training of specialized talent and the commercialization of medical platform technologies. They plan to expand cooperation across both K-beauty and K-medical sectors, building a virtuous cycle that runs from research and development through verification to commercialization.

"Developing functional products grounded in dermatological science, AI-powered personalized solutions and advanced biomaterial research are core areas we are focused on," Cosmax said. "This agreement will lay the foundation for elevating K-beauty to the next level."

K-beauty has in fact spread far beyond Asia, reaching North America, Europe and the Middle East. As the industry's global footprint widens, calls are growing for it to move beyond quantitative growth toward qualitative advancement and premiumization.

"We expect this partnership — bringing together Catholic University's outstanding educational and research infrastructure and Cosmax's global technology — to serve as a catalyst for elevating K-beauty and driving a qualitative leap forward for South Korea's medical, biotech and beauty industries," said Lee Kyung-su, chairman of Cosmax.